Browse drugs

… 13 (48%) patients remain on biologic treatment, 7 (26%) are on Azathioprine or an aminosalicylates and 7 (26%) have been able to discontinu…

…8 pts allocated 1:1:1 to GUS 400 mg SC every 4 weeks (q4w) (×3)→GUS 200 mg SC q4w (N=140), GUS 400 mg SC q4w (×3)→GUS 100 mg SC eve…

…d 32.1% of patients required restarting or uptitrating of their budesonide treatment due to a return of symptoms. In those requiring furth…

…reported in icotrokinra treatment groups through W12.Conclusion Icotrokinra, the first-in-class targeted oral peptide that selectively bloc…

… full analysis set, 113 received GUS 100mg SC Q8W, 115 received GUS 200mg SC Q4W, and 58 received PBO. 91.3% completed the 24 weeks…

… restricted with only 50.7% of services reporting access.In CD, vedolizumab was accessible in 64/71 services (90.1%), including 31 (43.7%) …

…uently treated with corticosteroids (79.3% vs. 67.9%, p=0.003), cyclophosphamide (43.4% vs. 26%, p<0.001), and azathioprine (38.5% vs. 22.3%, p=…

…analyze long term outcome of patients with SSc-ILD treated with tocilizumab (TCZ), rituximab (RTX), and abatacept (ABA) which became availa…

…urgitation. Exposure to immunosuppressive agents (methotrexate, mycophenolate mofetil, azathioprine, cyclophosphamide, tacrolimus, leflunomide, ritux…

…ac involvement was treated with CTX (CYCLOPS Regime) along with prednisone 40 mg.Both cases were closely monitored for their BP and renal …

…er distances. Similarly, access to multiple immunosuppressants (cyclophosphamide, azathioprine, methotrexate, tocilizumab) and vasoactive/vasodi…

…d. Immunosuppressive therapy with high-dose corticosteroids and azathioprine was initiated, leading to a gradual improvement of the encephal…